David Montani Selected Research

David Montani Research Topics

Disease

92	Pulmonary Arterial Hypertension 05/2024 - 01/2007
50	Pulmonary Hypertension 05/2024 - 07/2011
16	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 12/2022 - 10/2009
15	Familial Primary Pulmonary Hypertension 01/2020 - 01/2004
11	Hypoxia (Hypoxemia) 10/2022 - 01/2010
9	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2024 - 06/2011
7	Infections 06/2023 - 01/2004
7	Neoplasms (Cancer) 12/2022 - 07/2010
6	Heart Failure 10/2021 - 05/2012
6	Connective Tissue Diseases (Connective Tissue Disease) 01/2013 - 01/2004
5	Chronic Obstructive Pulmonary Disease (COPD) 03/2024 - 08/2015
5	Fibrosis (Cirrhosis) 11/2023 - 01/2013
5	Inflammation (Inflammations) 09/2015 - 09/2011
4	Vascular Diseases (Vascular Disease) 04/2024 - 11/2016
4	COVID-19 11/2023 - 03/2022
4	Hypertension (High Blood Pressure) 10/2023 - 01/2013
3	Systemic Scleroderma (Systemic Sclerosis) 11/2023 - 08/2016
3	Respiratory Insufficiency (Respiratory Failure) 06/2023 - 06/2011
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023 - 01/2017
3	Rare Diseases (Rare Disease) 12/2022 - 09/2015
3	Cystic Fibrosis (Mucoviscidosis) 12/2022 - 02/2007
3	Pleural Effusion (Pleural Effusions) 10/2020 - 11/2016
3	Sarcoidosis (Schaumann Disease) 10/2017 - 11/2015
3	Vascular Remodeling 11/2016 - 09/2009
3	Pulmonary Edema 04/2011 - 07/2008
3	Congenital Heart Defects (Congenital Heart Defect) 08/2010 - 01/2004
3	Portal Hypertension 08/2010 - 01/2004
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 07/2023
2	Genetic Predisposition to Disease (Genetic Predisposition) 03/2024 - 07/2023
2	Venous Thromboembolism 06/2023 - 01/2019
2	Lung Diseases (Lung Disease) 01/2023 - 01/2019
2	Disease Progression 01/2023 - 07/2011
2	Hypertrophy 02/2021 - 06/2014
2	Atrial Fibrillation 01/2021 - 01/2019
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2020 - 01/2019
2	Thrombosis (Thrombus) 01/2019 - 04/2016
2	Hemorrhage 01/2019 - 01/2010
2	Lymphadenopathy 11/2017 - 01/2010
2	Pneumonia (Pneumonitis) 01/2017 - 01/2017
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016 - 05/2012

Drug/Important Bio-Agent (IBA)

14	MonocrotalineIBA 01/2023 - 09/2011
9	Dasatinib (BMS 354825)FDA Link 03/2024 - 05/2012
8	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2017 - 07/2008
7	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 12/2022 - 06/2008
6	Biomarkers (Surrogate Marker)IBA 11/2023 - 08/2016
6	Carbon MonoxideIBA 01/2021 - 01/2010
5	Vasodilator Agents (Vasodilators)IBA 03/2024 - 07/2008
5	CytokinesIBA 01/2023 - 05/2011
5	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022 - 06/2011
5	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2021 - 09/2015
5	Tyrosine Kinase InhibitorsIBA 01/2018 - 05/2012
4	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2017
4	SolventsIBA 07/2023 - 12/2015
4	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2013
4	ProteomeIBA 01/2023 - 01/2017
4	Appetite Depressants (Anorectics)IBA 12/2022 - 01/2004
4	Phosphotransferases (Kinase)IBA 01/2018 - 10/2012
4	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 01/2018 - 01/2013
4	Endothelin Receptor AntagonistsIBA 01/2017 - 07/2011
4	Bosentan (Tracleer)FDA Link 01/2013 - 07/2008
3	treprostinil FDA Link 05/2024 - 04/2016
3	pro-brain natriuretic peptide (1-76)IBA 10/2023 - 01/2022
3	Imatinib Mesylate (Gleevec)FDA Link 10/2020 - 10/2012
3	bosutinibIBA 10/2020 - 11/2016
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2019 - 07/2008
3	potassium channel subfamily K member 3IBA 01/2019 - 04/2016
3	Phosphodiesterase 5 InhibitorsIBA 01/2017 - 09/2009
2	Diazoxide (Hyperstat)FDA Link 11/2023 - 01/2022
2	Oxygen (Dioxygen)IBA 08/2023 - 01/2023
2	Clostridium perfringens epsilon-toxinIBA 07/2023 - 11/2017
2	ACE-011IBA 01/2023 - 01/2021
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 01/2022
2	Dexfenfluramine (Redux)IBA 12/2022 - 10/2011
2	Immune Checkpoint InhibitorsIBA 12/2022 - 01/2017
2	benfluorex (S 780)IBA 12/2022 - 11/2012
2	FenfluramineIBA 12/2022 - 11/2012
2	riociguatIBA 10/2022 - 12/2015
2	AnticoagulantsIBA 03/2022 - 01/2019
2	LigandsIBA 10/2021 - 02/2021
2	IronIBA 07/2021 - 01/2017
2	Potassium Channels (Potassium Channel)IBA 01/2021 - 01/2020
2	ponatinibIBA 10/2020 - 02/2016
2	DNA (Deoxyribonucleic Acid)IBA 11/2017 - 01/2017
2	Prokaryotic Initiation Factor-2IBA 11/2017 - 01/2017
2	Caveolin 1IBA 09/2017 - 01/2017
2	EndoglinIBA 09/2017 - 01/2017
2	activin receptor type II-A (activin A receptor, type II)IBA 01/2017 - 04/2010
2	Prostaglandins IIBA 04/2016 - 01/2016
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2015 - 10/2012
2	Interleukin-6 (Interleukin 6)IBA 06/2014 - 04/2014
2	AntibodiesIBA 11/2013 - 02/2012
2	Sildenafil Citrate (Viagra)FDA Link 09/2013 - 09/2009

Therapy/Procedure

42	Therapeutics 03/2024 - 07/2008
9	Lung Transplantation 06/2023 - 11/2015
7	Transplantation 12/2023 - 02/2007
5	Drug Therapy (Chemotherapy) 07/2023 - 01/2015
2	Heart-Lung Transplantation 12/2023 - 08/2017
2	Aftercare (After-Treatment) 10/2021 - 07/2008
2	Hematopoietic Stem Cell Transplantation 01/2020 - 01/2019
2	Liver Transplantation 01/2020 - 01/2017